Dianne Spillman

575 citations
8 papers · 387 indexed · 1 hit paper · h-index 6
Topics
Lung Cancer Treatments and Mutations (3 papers)Autoimmune Bullous Skin Diseases (2 papers)Colorectal Cancer Treatments and Studies (2 papers)

In The Last Decade

Dianne Spillman

7 papers receiving 376 citations

Hit Papers

FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Me...2021202620222024202150100150

Peers

Dianne Spillman
Comparison fields: 5 of 62
  • Oncology 179
  • Molecular Biology 144
  • Pulmonary and Respiratory Medicine 131
  • Cancer Research 62
  • Pathology and Forensic Medicine 44
Replace Herb Kotz with:
Herb Kotz United States
Karel Cwiertka Czechia
Gustavo Ismael Belgium
Hal Hirte Canada
Sundersingh Shirley India
Dan Chan United States
A. Yovine United States
Yann Bergé France
Heidi Nauwelaerts Switzerland
Dianne Spillman relative to Herb Kotz United States Herb Kotz's profile →
Citations per field
00.5×10×20×26×
Herb Kotz · 1×
Citations per year

Countries citing papers authored by Dianne Spillman

Since Specialization
Citations

This map shows the geographic impact of Dianne Spillman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianne Spillman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianne Spillman more than expected).

Fields of papers citing papers by Dianne Spillman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianne Spillman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianne Spillman. The network helps show where Dianne Spillman may publish in the future.

Co-authorship network of co-authors of Dianne Spillman

This figure shows the co-authorship network connecting the top 25 collaborators of Dianne Spillman. A scholar is included among the top collaborators of Dianne Spillman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianne Spillman. Dianne Spillman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 42
2
FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLCbreakdown →
193
3 41
4 63
5 0
6 37
7 10
8
[Bullous muco-synechial dermatitis atrophicans. Development and current nosological status].
1

About Dianne Spillman

Dianne Spillman is a scholar working on Hematology, Pathology and Forensic Medicine and Obstetrics and Gynecology, having authored 8 papers that have together received 387 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (3 papers), Autoimmune Bullous Skin Diseases (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (179 citations), Cancer Research (62 citations) and Pulmonary and Respiratory Medicine (131 citations). Dianne Spillman has collaborated with scholars based in United States, Canada and Singapore. Frequent co-authors include Julia A. Beaver, Richard Pazdur, Emily M. Haymes, Harpreet Singh, Nicole Drezner, Pallavi S. Mishra‐Kalyani, Jiang Liu, Xiaoxue Li, Hong Zhao and Emily Wearne. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Sports Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026